{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:23Z","timestamp":1792784243315,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Zytoprotec GmbH Austria"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.kint.2018.08.031","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:30:23Z","timestamp":1540204223000},"page":"1227-1237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to\u00a0assess impact on biomarkers of peritoneal\u00a0health"],"prefix":"10.1016","volume":"94","author":[{"given":"Andreas","family":"Vychytil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Ribitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-7775","authenticated-orcid":false,"given":"Karl","family":"Lhotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Machold-Fabrizii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wiesholzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Salmhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Windpessl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kratochwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Aufricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.08.031_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/039139889201500203","article-title":"Biocompatibility of peritoneal dialysis fluids","volume":"15","author":"J\u00f6rres","year":"1992","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.kint.2018.08.031_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrneph.2012.13","article-title":"An update on peritoneal dialysis solutions","volume":"8","author":"Garcia-Lopez","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.08.031_bib3","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.031_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.kint.2018.02.022","article-title":"Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"issue":"suppl 3","key":"10.1016\/j.kint.2018.08.031_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ndt\/17.suppl_3.12","article-title":"Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions","volume":"17","author":"Devuyst","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/089686080902900604","article-title":"Factors contributing to peritoneal tissue remodeling in peritoneal dialysis","volume":"29","author":"Schilte","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.08.031_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrneph.2013.99","article-title":"Peritoneal changes in patients on long-term peritoneal dialysis","volume":"9","author":"Krediet","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2018.08.031_bib8","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","article-title":"What really happens to people on long-term peritoneal dialysis?","volume":"54","author":"Davies","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib9","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/ndt\/gfq003","article-title":"Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account","volume":"25","author":"Evans","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.2013.190","article-title":"The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients","volume":"84","author":"Cho","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib11","first-page":"CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"3","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2018.08.031_bib12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ndt\/gfq484","article-title":"Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells","volume":"26","author":"Bender","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ndt\/gfr459","article-title":"Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids","volume":"27","author":"Kratochwill","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib14","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1152\/ajprenal.00503.2005","article-title":"Evidence for HSP-mediated cytoskeletal stabilization in mesothelial cells during acute experimental peritoneal dialysis","volume":"292","author":"Endemann","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2018.08.031_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1523-1755.2000.00883.x","article-title":"Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis","volume":"57","author":"Shioshita","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib16","first-page":"2025S","article-title":"Nonnutritive effects of glutamine","volume":"138","author":"Roth","year":"2008","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2018.08.031_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3747\/pdi.2009.00024","article-title":"HSP-mediated cytoprotection of mesothelial cells in experimental acute peritoneal dialysis","volume":"30","author":"Bender","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.kint.2018.08.031_bib18","doi-asserted-by":"crossref","first-page":"e0165045","DOI":"10.1371\/journal.pone.0165045","article-title":"Addition of alanyl-glutamine to dialysis fluid restores peritoneal cellular stress responses: a first-in-man trial","volume":"11","author":"Kratochwill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.08.031_bib19","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1038\/s41598-017-05872-2","article-title":"Functional and transcriptomic characterization of peritoneal immune-modulation by addition of alanyl-glutamine to dialysis fluid","volume":"7","author":"Herzog","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.08.031_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis","volume":"89","author":"Ferrantelli","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","article-title":"Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","volume":"92","author":"Aufricht","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.08.031_bib23","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gfp054","article-title":"Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study","volume":"24","author":"Kim","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib24","doi-asserted-by":"crossref","first-page":"e0141425","DOI":"10.1371\/journal.pone.0141425","article-title":"The effect of neutral peritoneal dialysis solution with low glucose-degradation-product on the fluid status and body composition--a randomized control trial","volume":"10","author":"Szeto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2018.08.031_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/089686088700700306","article-title":"Peritoneal equilibration test","volume":"7","author":"Twardowski","year":"1987","journal-title":"Perit Dial Bull"},{"key":"10.1016\/j.kint.2018.08.031_bib26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2215\/CJN.01910309","article-title":"Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients","volume":"4","author":"Perl","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.031_bib27","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1093\/ndt\/gfs385","article-title":"Peritoneal transport: getting more complicated","volume":"27","author":"Heaf","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2018.08.031_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1096\/fasebj.13.3.563","article-title":"Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression","volume":"13","author":"Spittler","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2018.08.031_bib29","doi-asserted-by":"crossref","first-page":"697972","DOI":"10.1155\/2013\/697972","article-title":"Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide","volume":"2013","author":"Schildberger","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.kint.2018.08.031_bib30","first-page":"129","article-title":"Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients","volume":"25","author":"Ploder","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.kint.2018.08.031_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00000658-200301000-00015","article-title":"Perioperative GLY-GLN infusion diminishes the surgery-induced period of immunosuppression: accelerated restoration of the lipopolysaccharide-stimulated tumor necrosis factor-alpha response","volume":"237","author":"Exner","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.kint.2018.08.031_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ACO.0b013e3282f54fd6","article-title":"Role of glutamine supplementation in critically ill patients","volume":"21","author":"Wernerman","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.kint.2018.08.031_bib33","first-page":"2515S","article-title":"Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?","volume":"131","author":"Newsholme","year":"2001","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2018.08.031_bib34","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.V86.4.1564.bloodjournal8641564","article-title":"Influence of glutamine on the phenotype and function of human monocytes","volume":"86","author":"Spittler","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.08.031_bib35","first-page":"CD010050","article-title":"Glutamine supplementation for critically ill adults","volume":"9","author":"Tao","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2018.08.031_bib36","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1046\/j.1523-1755.2003.08809.x","article-title":"Clinical indices of in\u00a0vivo biocompatibility: the role of ex\u00a0vivo cell function studies and effluent markers in peritoneal dialysis patients","volume":"88","author":"Mackenzie","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2018.08.031_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcp.20339","article-title":"Molecular mechanisms of glutamine action","volume":"204","author":"Curi","year":"2005","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.kint.2018.08.031_bib38","doi-asserted-by":"crossref","first-page":"40400","DOI":"10.1074\/jbc.M112.410712","article-title":"Glutamine-mediated dual regulation of heat shock transcription factor-1 activation and expression","volume":"287","author":"Xue","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"suppl 9","key":"10.1016\/j.kint.2018.08.031_bib39","doi-asserted-by":"crossref","first-page":"S541","DOI":"10.1097\/01.CCM.0000278064.32780.D3","article-title":"Glutamine: mode of action in critical illness","volume":"35","author":"Wischmeyer","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.kint.2018.08.031_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccc.2010.04.006","article-title":"Glutamine in critical illness: the time has come, the time is now","volume":"26","author":"Weitzel","year":"2010","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.kint.2018.08.031_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1074\/mcp.RA117.000186","article-title":"Effects of alanyl-glutamine treatment on the peritoneal dialysis effluent proteome reveal pathomechanism-associated molecular signatures","volume":"17","author":"Herzog","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.kint.2018.08.031_bib42","doi-asserted-by":"crossref","first-page":"C1625","DOI":"10.1152\/ajpcell.00635.2005","article-title":"Glutamine's protection against cellular injury is dependent on heat shock factor-1","volume":"290","author":"Morrison","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2018.08.031_bib43","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2013101128","article-title":"Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelial cells exposed to peritoneal dialysis fluids","volume":"25","author":"Herzog","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2018.08.031_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clnu.2007.12.003","article-title":"Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study","volume":"27","author":"Luo","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.kint.2018.08.031_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0148607110362587","article-title":"The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials","volume":"34","author":"Wang","year":"2010","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.kint.2018.08.031_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0029665109001384","article-title":"Hot topics in parenteral nutrition: a review of the use of glutamine supplementation in the nutritional support of patients undergoing bone-marrow transplantation and traditional cancer therapy","volume":"68","author":"Crowther","year":"2009","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.kint.2018.08.031_bib47","first-page":"2040S","article-title":"Clinical use of glutamine supplementation","volume":"138","author":"Wernerman","year":"2008","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2018.08.031_bib48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.CCM.0000196829.30741.D4","article-title":"Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients","volume":"34","author":"Bakalar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.kint.2018.08.031_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.CCM.0000201004.30750.D1","article-title":"L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study","volume":"34","author":"Dechelotte","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.kint.2018.08.031_bib50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/089686080902900404","article-title":"Amino acid-based peritoneal dialysis solutions for malnutrition: new perspectives","volume":"29","author":"Tjiong","year":"2009","journal-title":"Perit Dial Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818306379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:51:34Z","timestamp":1758761494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818306379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0085253818306379"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.031","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to\u00a0assess impact on biomarkers of peritoneal\u00a0health","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}